Related Insights
Dark Fleet Tactics Complicate Insurance Underwriting Across Gulf Shipping
The rise of covert dark fleet operations is reshaping risk assessment for Gulf shipping. Marine insurers face new challenges in pricing tanker and chemical cargoes amid sanctions and security threats. Learn how regulators and logistics firms adapt.
IMO's 49 Incidents: The Definitive Safety Record and What It Means for Chemical Tanker Risk
The International Maritime Organization has confirmed 49 security incidents across Hormuz and the Persian Gulf as of June 30, creating the most comprehensive official risk dataset of the 2026 shipping crisis. For chemical tanker operators and cargo buyers, this record now defines insurance underwriting and shipping risk calculations for H2 2026.
Commodity Chemical Intelligence: The Kpler 34 Framework for Reading Physical Recovery vs Diplomatic Progress
The most important lesson from 124 days of the 2026 Hormuz crisis is that physical supply recovery and diplomatic progress move independently. For chemical procurement teams planning Q3 supply, vessel crossing data from Kpler now matters far more than political statements coming out of Doha negotiations.
Taurine Supply Chain 2026: MEA Feedstock Trends and Procurement Outlook
Despite volatile monoethanolamine and ethylene oxide markets, taurine supply remains resilient. Chinese producers are offsetting feedstock pressures, offering stability for H2 2026. Supplement makers must reassess sourcing strategies to secure this dependable supply.
MEG After India's Duty Reinstatement: Understanding the New Landed Cost Arithmetic for Polyester Buyers
India's reinstatement of the 5% Basic Customs Duty on MEG imports changes the cost equation for polyester manufacturers and chemical buyers. This article explains the new landed cost arithmetic, why today's costs remain below April's market peak and what procurement teams should monitor in the months ahead.
Pharmaceutical Solvents: H1 Closing Review and H2 Procurement Window
Pharmaceutical solvent markets are entering H2 2026 with improving feedstock economics and stabilizing crude oil prices. This creates an ideal procurement window for pharmaceutical manufacturers to secure long-term solvent supply agreements before potential market volatility returns.
Don't miss out on our updates! Subscribe to our newsletter now
We're committed to your privacy. Tradeasia uses the information you provide to us to contact you about our relevant content, products, and services. For more information, check out our privacy policy.